Who owns RAPT THERAPEUTICS INC?
- Ticker: RAPT
- CUSIP Number: 75382e208
Tip: Access positions for across all investors
Analyze quarterly positions in Rapt Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Rapt Therapeutics stock
Who bought or sold RAPT THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| TCG Crossover Management | 2.6M | $88M | 58% | Dec 2025 |
|
| Fcpm Iii Services B.v. | 1.8M | $62M | 433% | Dec 2025 |
|
| OrbiMed Advisors | 1.6M | $56M | 51% | Dec 2025 |
|
| Rtw Investments | 1.6M | $56M | 11% | Dec 2025 |
|
| Foresite Capital Management VI | 1.6M | $53M | 0% | Dec 2025 |
|
| Siren | 1.4M | $47M | 137% | Dec 2025 |
|
| Vanguard Group | 1.2M | $40M | 70% | Dec 2025 |
|
| Frazier Life Sciences Management | 983k | $33M | 100% | Dec 2025 |
|
| Ikarian Capital | 955k | $32M | 21% | Dec 2025 |
|
| Braidwell | 930k | $32M | 100% | Dec 2025 |
|
| Soleus Capital Management | 764k | $26M | 42% | Dec 2025 |
|
| Nantahala Capital Management | 754k | $26M | 21% | Dec 2025 |
|
| Caligan Partners | 644k | $22M | 100% | Dec 2025 |
|
| State Street Corporation | 640k | $22M | 1611% | Dec 2025 |
|
| Dr. Jeffrey R. Jay, M.D. | 581k | $20M | 100% | Dec 2025 |
|
| Octagon Capital Advisors | 574k | $19M | 100% | Dec 2025 |
|
| Redmile Group | 553k | $14M | -12% | Sep 2025 |
|
| ADAR1 Capital Management | 510k | $17M | 0% | Dec 2025 |
|
| BlackRock | 486k | $17M | 443% | Dec 2025 |
|
| Susquehanna International | 472k | $16M | 941% | Dec 2025 |
|
| Boone Capital Management | 471k | $16M | -40% | Dec 2025 |
|
| Boothbay Fund Management | 470k | $16M | 64% | Dec 2025 |
|
| MPM Oncology Impact Management | 398k | $14M | 100% | Dec 2025 |
|
| Goldman Sachs Group | 254k | $8.6M | 313% | Dec 2025 |
|
| Commodore Capital | 250k | $8.5M | 100% | Dec 2025 |
|
| FMR | 248k | $6.4M | 12729% | Sep 2025 |
|
| Geode Capital Management | 240k | $8.1M | 97% | Dec 2025 |
|
| Rock Springs Capital Management | 214k | $7.2M | 100% | Dec 2025 |
|
| Perceptive Advisors | 184k | $4.7M | 0% | Sep 2025 |
|
| Invesco | 167k | $5.7M | 19% | Dec 2025 |
|
| AWM Investment Company | 163k | $5.5M | 100% | Dec 2025 |
|
| Qube Research & Technologies | 158k | $5.4M | 100% | Dec 2025 |
|
| Jane Street | 154k | $5.2M | 100% | Dec 2025 |
|
| Opaleye Management | 150k | $213k | 100% | Dec 2025 |
|
| Polygon Management | 132k | $4.5M | 100% | Dec 2025 |
|
| Deep Track Capital | 110k | $3.7M | -85% | Dec 2025 |
|
| Caption Management | 110k | $3.7M | 100% | Dec 2025 |
|
| Velan Capital Investment Management | 108k | $3.7M | 35% | Dec 2025 |
|
| Atika Capital Management | 94k | $3.2M | 100% | Dec 2025 |
|
| Renaissance Technologies | 91k | $3.1M | 166% | Dec 2025 |
|
| Marshall Wace | 85k | $2.9M | 402% | Dec 2025 |
|
| Euclidean Capital | 82k | $2.8M | 0% | Dec 2025 |
|
| Barclays | 77k | $2.6M | 80594% | Dec 2025 |
|
| UBS Group | 66k | $2.2M | 130% | Dec 2025 |
|
| Quadrature Capital | 58k | $2.0M | 100% | Dec 2025 |
|
| Trexquant Investment | 54k | $1.8M | 100% | Dec 2025 |
|
| Balyasny Asset Management | 50k | $1.3M | 100% | Sep 2025 |
|
| Burkehill Global Management | 50k | $1.7M | 100% | Dec 2025 |
|
| Connor, Clark & Lunn Investment Management | 49k | $1.7M | 100% | Dec 2025 |
|
| Northern Trust | 41k | $1.4M | 138% | Dec 2025 |
|
| Millennium Management | 39k | $1.0M | 75% | Sep 2025 |
|
| Two Sigma Investments | 35k | $898k | -20% | Sep 2025 |
|
| Citadel Advisors | 34k | $883k | 137% | Sep 2025 |
|
| Rafferty Asset Management | 33k | $1.1M | 100% | Dec 2025 |
|
| Point72 Asset Management | 25k | $853k | 103% | Dec 2025 |
|
| Squarepoint Ops | 25k | $832k | 100% | Dec 2025 |
|
| GSA Capital Partners | 23k | $777k | 117% | Dec 2025 |
|
| Landscape Capital Management | 23k | $774k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 21k | $532k | 32% | Sep 2025 |
|
| Sigma Planning | 19k | $644k | 100% | Dec 2025 |
|
| Man Group | 19k | $637k | 100% | Dec 2025 |
|
| XTX Topco | 18k | $616k | 100% | Dec 2025 |
|
| Acadian Asset Management | 17k | $568k | 0% | Dec 2025 |
|
| Nomura Holdings | 16k | $552k | 100% | Dec 2025 |
|
| Birchview Capital | 15k | $508k | 100% | Dec 2025 |
|
| Royal Bank of Canada | 15k | $376k | 0% | Sep 2025 |
|
| Exome Asset Management | 14k | $481k | 100% | Dec 2025 |
|
| HighTower Advisors | 13k | $424k | -1% | Dec 2025 |
|
| ProFund Advisors | 12k | $403k | 100% | Dec 2025 |
|
| OMERS Administration Corporation | 12k | $393k | 100% | Dec 2025 |
|
| Y-Intercept | 11k | $381k | 100% | Dec 2025 |
|
| American Century Companies | 10k | $346k | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 10k | $339k | 0% | Dec 2025 |
|
| Jump Financial | 9.8k | $333k | 100% | Dec 2025 |
|
| Engineers Gate Manager | 9.8k | $331k | 100% | Dec 2025 |
|
| Dimensional Fund Advisors | 8.9k | $303k | 0% | Dec 2025 |
|
| Hudson Bay Capital Management | 8.9k | $301k | 100% | Dec 2025 |
|
| Jain Global | 7.4k | $251k | 100% | Dec 2025 |
|
| Voloridge Investment Management | 6.9k | $234k | 100% | Dec 2025 |
|
| Bank of Nova Scotia | 6.7k | $227k | 100% | Dec 2025 |
|
| Group One Trading | 5.3k | $179k | 96% | Dec 2025 |
|
| China Universal Asset Management | 4.5k | $153k | 100% | Dec 2025 |
|
| Tower Research Capital | 3.1k | $105k | 100% | Dec 2025 |
|
| Simplex Trading | 2.8k | $96k | 100% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 1.9k | $64k | 100% | Dec 2025 |
|
| Mirae Asset Global Investments | 1.3k | $46k | 100% | Dec 2025 |
|
| Gf Fund Management | 544.00 | $18k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 498.00 | $17k | 530% | Dec 2025 |
|
| Pnc Financial Services | 497.00 | $17k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 323.00 | $8.3k | 100% | Sep 2025 |
|
| Daiwa Securities Group | 92.00 | $3.0k | 100% | Dec 2025 |
|
| NISA Investment Advisors | 79.00 | $2.7k | 0% | Dec 2025 |
|
| Fortitude Family Office | 63.00 | $2.1k | 0% | Dec 2025 |
|
| CWM | 32.00 | $1.0k | -72% | Dec 2025 |
|
| EverSource Wealth Advisors | 20.00 | $680.000000 | -66% | Dec 2025 |
|
| Point72 | 16.00 | $405.000000 | 100% | Sep 2025 |
|
| Bessemer | 11.00 | $0 | 0% | Dec 2025 |
|
| Aster Capital Management | 1.00 | $34.000000 | 100% | Dec 2025 |
|
Who sold out of Rapt Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BVF | Jun 2025 | 1.2M | $9.2M |
| SummitTX Capital | Sep 2025 | 92k | $2.4M |
| Ameriprise Financial | Sep 2025 | 51k | $1.3M |
| Superstring Capital Management | Sep 2025 | 34k | $888k |
| Two Sigma Advisers | Jun 2025 | 24k | $189k |
| Trustees of Columbia University in the City of New York | Sep 2025 | 9.2k | $237k |
| Russell Investments | Sep 2025 | 1.1k | $28k |
| Banque Cantonale Vaudoise | Sep 2025 | 154.00 | $7.0k |
| SRS Capital Advisors | Sep 2025 | 1.00 | $25.000000 |